SKP2 and neoplasm: In addition, Wei Wenyi’s team found that the K68/K71 acetylation modification of SKP2 can promote its cytoplasmic localization and enhance tumor metastasis by degrading E-cadherin, while SIRT3 deacetylase can reverse this process (52).